The link between depression and dementia Over 55 million people currently have dementia, with almost 10 million new diagnoses every year. At the same time, about 280 million people suffer from major depression — and adults over 60 are affected at the highest rates. While depression and dementia might seem unrelated, people with depression are 1.5 times as likely to develop dementia. This suggests depression may initiate or exacerbate the neurodegenerative processes of dementia. - Psilocybin for brain health Psilocybin enhances neuroplasticity — the brain’s natural ability to reorganize itself and form new neural connections. Think of neuroplasticity as how well your brain adapts to new experiences. - Potential treatment Psilocybin’s ability to enhance neuroplasticity could be a crucial way to fight neurodegenerative diseases like dementia, which lead to deteriorating cognitive function. - Begone, inflammation! Chronic inflammation is a major contributor to neurodegenerative disease. Psilocybin’s anti-inflammatory properties show promising potential for neural health. By reducing brain inflammation, psilocybin could protect against neural damage, like a shield for regions of the brain that are more prone to degenerating. - Psilocybin for neuron formation Adult hippocampal neurogenesis (AHN) is the process of forming new neurons. This process is crucial for learning, forming memories, and regulating emotions as we age. - High-risk AHN is extremely vulnerable to Dementia. A lack of new neuron formation contributes to cognitive decline. Psilocybin can stimulate AHN and reduce the inflammatory responses that are central to dementia progression. - Future implications Psilocybin could be a groundbreaking solution to help delay dementia — especially since early treatment is vital to combat neurodegenerative diseases. Further research is necessary to develop targeted therapeutic strategies that will optimize psilocybin’s neuroprotective properties.